Esperance Pharmaceuticals, Inc — Form D
Esperance Pharmaceuticals, Inc of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2019-07-12. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-07-12
- Form: D
- Accession: 0001451464-19-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 1
- Date of first sale: 2019-06-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-344116
Issuer
- Name: Esperance Pharmaceuticals, Inc
- CIK: 0001451464
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2005
- Address: TWO HOUSTON CENTER, HOUSTON, TX, 77010
- Phone: 713-276-7600
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Hector Alila | Director | Houston, TX |
| Ross Barrett | Director | Shreveport, LA |
| Peter Hoang | Director | Houston, TX |
| Joseph Lovett | Director | Houston, TX |
| Hector Alila | Executive Officer | Houston, TX |
| Sonia Deggs | Executive Officer | Houston, TX |
| Carola Leuschner | Executive Officer | Houston, TX |
| Richard Babb | Executive Officer | Hammond, LA |
| Chad Souvignier | Director | Hayward, CA |
Other filings by this issuer (3)
More